UBS raised the firm’s price target on Marex Group (MRX) to $60 from $56 and keeps a Buy rating on the shares. Meetings with CEO Ian Lowitt highlighted incremental avenues of growth that were not previously anticipated, supporting an increase in the revenue growth outlook to 15%-20% from 10%-15%, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRX:
- Marex Group price target raised to $60 from $56 at UBS
- Marex Group price target raised to $66 from $61 at TD Cowen
- Marex Group price target raised to $55 from $50 at Barclays
- Marex Group Plans Bermuda Redomiciliation as It Forecasts Record Q1 2026 Results
- Marex Group sees Q1 revenue $667M-$697M, consensus $588.75M